Physician profile
David C Benson
NPI 1093703035
$1,001.42
in general payments reported to CMS, 2019-2025
11 companies · $41.60 in 2025
The $41.60 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.01 · 2020: $159 · 2021: $190 · 2022: $182 · 2023: $260 · 2024: $137 · 2025: $41.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $439.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $362.99 | 2020-2024 | Moses 550 D\F\L, Lithovue, Moses 550 Dfl |
| Coloplast Corp | $308.05 | 2021-2022 | |
| Edap Technomed INC | $135.71 | 2020 | |
| Innovation Technologies INC | $74.70 | 2024-2025 | Irrisept |
| Astellas Pharma US INC | $24.57 | 2021 | |
| Urogen Pharma, INC. | $23.71 | 2024 | |
| Antares Pharma, INC. | $16.15 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.86 | 2019 | |
| Abc Home Medical Supply, INC. | $14.05 | 2022 | |
| Cook Medical LLC | $13.62 | 2025 | Litho 150 |
| Progenics Pharmaceuticals, INC. | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.